Newborn Genetic Screening: Nadonda NBS Series

Newborn Genetic Screening: Nadonda NBS Series

✨ NGS Technology Breaks New Ground! Newborn Genetic Screening Adds More "Lines of Defense" for HealthWith the maturity of Next-Generation Sequencing (NGS) technology, newborn genetic screening has finally arrived—it does not test "biochemical indicators" but directly analyzes a baby’s DNA, acting like a "genetic detective" to identify hidden genetic disease risks.
Compared with traditional screening, its advantages are crucial:
Wide Disease Coverage: It can detect over 100 diseases in one test, covering multiple systems including inborn errors of metabolism, neurology, hematology, and immunology (e.g., thalassemia, SMA, and phenylketonuria are all included);
Higher Accuracy: Complementary to traditional screening, it significantly reduces false positives/negatives and avoids "missed cases";
Early Intervention Opportunities: It directly identifies the genetic cause of diseases and shortens the diagnosis time—for example, if a metabolic disease is detected, early dietary adjustments can prevent brain damage; if an immunodeficiency is found, early protection can reduce the risk of infection.
In short: Traditional screening is a "basic check-up," while genetic screening is a "precision upgrade." Only by combining the two can we provide more comprehensive protection for babies.